Riyaz Patel

ORCID: 0000-0003-4603-2393
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Lipoproteins and Cardiovascular Health
  • Acute Myocardial Infarction Research
  • Genetic Associations and Epidemiology
  • Health Systems, Economic Evaluations, Quality of Life
  • Cardiovascular Health and Risk Factors
  • Cardiac Health and Mental Health
  • Atrial Fibrillation Management and Outcomes
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Cardiovascular Disease and Adiposity
  • Chronic Disease Management Strategies
  • Sepsis Diagnosis and Treatment
  • Cardiovascular Function and Risk Factors
  • Adipokines, Inflammation, and Metabolic Diseases
  • Health Promotion and Cardiovascular Prevention
  • Cardiac, Anesthesia and Surgical Outcomes
  • Cardiac Imaging and Diagnostics
  • Liver Disease Diagnosis and Treatment
  • Venous Thromboembolism Diagnosis and Management
  • Cardiovascular Health and Disease Prevention
  • Primary Care and Health Outcomes
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Acute Ischemic Stroke Management
  • Machine Learning in Healthcare
  • Emergency and Acute Care Studies
  • COVID-19 and healthcare impacts

University College London
2016-2025

St Bartholomew's Hospital
2016-2025

Barts Health NHS Trust
2015-2025

National Institute for Health Research
2017-2025

UCL Biomedical Research Centre
2019-2024

University College London Hospitals NHS Foundation Trust
2018-2024

Narsee Monjee Institute of Management Studies
2024

CHI Health Creighton University Medical Center - Bergan Mercy
2024

Health Data Research UK
2018-2023

British Heart Foundation
2019-2023

Coronary artery disease (CAD) has substantial heritability and a polygenic architecture. However, the potential of genomic risk scores to help predict CAD outcomes not been evaluated comprehensively, because available studies have involved limited scope sample sizes. This study sought construct score for estimate its as screening tool primary prevention. Using meta-analytic approach combine large-scale, genome-wide, targeted genetic association data, we developed new (metaGRS) consisting 1.7...

10.1016/j.jacc.2018.07.079 article EN cc-by Journal of the American College of Cardiology 2018-10-01

Mendelian randomisation (MR) analysis is an important tool to elucidate the causal relevance of environmental and biological risk factors for disease. However, inference undermined if genetic variants used instrument a factor also influence alternative disease-pathways (horizontal pleiotropy). Here we report how 'no horizontal pleiotropy assumption' strengthened when proteins are interest. Proteins typically proximal effectors processes encoded in genome. Moreover, targets most medicines, so...

10.1038/s41467-020-16969-0 article EN cc-by Nature Communications 2020-06-26
Amand F. Schmidt Daniel I. Swerdlow Michael V. Holmes Riyaz Patel Zammy Fairhurst-Hunter and 95 more Donald M. Lyall Fernando Pires Hartwig Bernardo Lessa Horta Elina Hyppönen Christine Power Max Moldovan Erik Van Iperen G. Kees Hovingh Ilja Demuth Kristina Norman Elisabeth Steinhagen‐Thiessen Juri Demuth Lars Bertram Tian Liu Stefan Coassin Johann Willeit Stefan Kiechl Karin Willeit Dan Mason John Wright Richard Morris Goya Wanamethee Peter H. Whincup Yoav Ben‐Shlomo Stela McLachlan Jackie F. Price Mika Kivimäki Catherine Welch Adelaida Sánchez-Gálvez Pedro Marques‐Vidal Andrew Nicolaides Andrie G. Panayiotou N. Charlotte Onland‐Moret Yvonne T. van der Schouw Giuseppe Matullo Giovanni Fiorito Simonetta Guarrera Carlotta Sacerdote Nicholas J. Wareham Claudia Langenberg Robert A. Scott Jian’an Luan Martin Bobák Sofia Malyutina Andrzej Pająk Růžena Kubínová Abdonas Tamošiūnas Hynek Pikhart Lise Lotte N. Husemoen Niels Grarup Oluf Pedersen Torben Hansen Allan Linneberg Kenneth Starup Simonsen Jackie A. Cooper Steve E. Humphries Murray H. Brilliant Terrie Kitchner Hákon Hákonarson David Carrell Catherine A. McCarty H. Lester Kirchner Eric B. Larson David R. Crosslin Mariza de Andrade Dan M. Roden Joshua C. Denny Cara L. Carty Stephen Hancock John Attia Elizabeth G. Holliday Martin O’Donnell Salim Yusuf Michael Chong Guillaume Paré Pim van der Harst M. Abdullah Said Ruben N. Eppinga Niek Verweij Harold Snieder Tim Christen Dennis O. Mook‐Kanamori Stefan Gustafsson Lars Lind Erik Ingelsson Raha Pazoki Oscar H. Franco Albert Hofman André G. Uitterlinden Abbas Dehghan Alexander Teumer Sebastian E. Baumeister Marcus Dörr Markus M. Lerch Uwe Völker

Statin treatment and variants in the gene encoding HMG-CoA reductase are associated with reductions both concentration of LDL cholesterol risk coronary heart disease, but also modest hyperglycaemia, increased bodyweight, modestly type 2 diabetes, which no way offsets their substantial benefits. We sought to investigate associations cholesterol-lowering PCSK9 diabetes related biomarkers gauge likely effects inhibitors on risk.In this mendelian randomisation study, we used data from cohort...

10.1016/s2213-8587(16)30396-5 article EN cc-by The Lancet Diabetes & Endocrinology 2016-11-28

Abstract Objective Electronic health records (EHRs) are a rich source of information on human diseases, but the is variably structured, fragmented, curated using different coding systems, and collected for purposes other than medical research. We describe an approach developing, validating, sharing reproducible phenotypes from national structured EHR in United Kingdom with applications translational Materials Methods implemented rule-based phenotyping framework, up to 6 approaches...

10.1093/jamia/ocz105 article EN cc-by Journal of the American Medical Informatics Association 2019-05-30

Cardiac death is the leading cause of mortality in patients with sarcoidosis, yet cardiac involvement often remains undetected. Cardiovascular magnetic resonance imaging (CMR) and 18F-fluorodeoxyglucose (FDG)-positron emission tomography (PET) have been used to diagnose sarcoidosis (CS) never simultaneously a cohort. This study sought assess diagnostic prognostic utility simultaneous hybrid PET/MR.Fifty-one consecutive suspected CS (age 50 ± 13 years, 31 males) underwent PET/MR following...

10.1093/ehjci/jex340 article EN European Heart Journal - Cardiovascular Imaging 2017-12-15

Epidemiological studies show that high circulating cystatin C is associated with risk of cardiovascular disease (CVD), independent creatinine-based renal function measurements. It unclear whether this relationship causal, arises from residual confounding, and/or a consequence reverse causation. The aim study was to use Mendelian randomization investigate causally related CVD in the general population. We incorporated participant data 16 prospective cohorts (n = 76,481) 37,126 measures and...

10.1016/j.jacc.2016.05.092 article EN cc-by-nc-nd Journal of the American College of Cardiology 2016-08-01

Background Young women with coronary heart disease have high rates of depression and a higher risk adverse events than men similar age. Whether has prognostic value in this group older is not known. Our objective was to assess whether young associated artery ( CAD ) outcomes compared similarly aged women. Methods Results We examined 3237 patients undergoing angiography for evaluation followed them 2.9 years (median). Depressive symptoms were assessed the Patient Health Questionnaire PHQ )‐9,...

10.1161/jaha.113.000741 article EN cc-by-nc-nd Journal of the American Heart Association 2014-05-22

Abstract Aims The prognosis of patients hospitalized for worsening heart failure ( HF ) is well described, but not that managed solely in non‐acute settings such as primary care or secondary outpatient care. We assessed the distribution across levels healthcare, and prognostic differences with either recorded (including care) PC ), hospital admissions alone, known both contexts. Methods results This study was part CALIBER programme, which comprises linked data from care, admissions, death...

10.1002/ejhf.709 article EN cc-by European Journal of Heart Failure 2016-12-23

•Variants in metal ion transporter and NAFLD genes are associated with liver MRI-derived cT1, a steatohepatitis fibrosis proxy.•cT1 is highly heritable, correlated BMI, VLDL, inversely HDL.•Insulin resistance, higher BMI genetically linked to whilst favourable adiposity lower cT1. Background & AimsMRI-based corrected T1 (cT1) non-invasive method grade the severity of fibrosis. We aimed identify genetic variants influencing cT1 use genetics understand mechanisms underlying fibroinflammatory...

10.1016/j.jhep.2020.03.032 article EN cc-by Journal of Hepatology 2020-04-02

Abstract Following numerous genome-wide association studies of disease susceptibility, there is increasing interest in genetic associations with prognosis, survival or other subsequent events. Such are vulnerable to index event bias, by which selection subjects according status creates biased if common causes incidence and prognosis not accounted for. We propose an adjustment for bias using the residuals from regression effects on incidence. Our approach eliminates this when direct...

10.1038/s41467-019-09381-w article EN cc-by Nature Communications 2019-04-05

Background National electronic health records (EHR) are increasingly used for research but identifying disease cases is challenging due to differences in information captured between sources (e.g. primary and secondary care). Our objective was provide a transparent, reproducible model integrating these data using atrial fibrillation (AF), chronic condition diagnosed managed multiple ways different healthcare settings, as case study. Methods Potentially relevant codes AF screening, diagnosis,...

10.1371/journal.pone.0110900 article EN cc-by PLoS ONE 2014-11-04
Stephen Zewinger Marcus E. Kleber Vinicius Tragante Raymond O. McCubrey Amand F. Schmidt and 95 more Kenan Direk Ulrich Laufs Christian Werner Wolfgang Köenig Dietrich Rothenbacher Ute Mons Lutz P. Breitling Hermann Brenner Richard T. Jennings Ioannis Petrakis Sarah Triem Mira Klug Alexandra Filips Stefan Blankenberg Christoph Waldeyer Christoph Sinning Renate B. Schnabel Karl J. Lackner Efthymia Vlachopoulou Ottar Nygård Gard Frodahl Tveitevåg Svingen Eva Ringdal Pedersen Grethe S. Tell Juha Sinisalo Markku S. Nieminen Reijo Laaksonen Stella Trompet Roelof A.J. Smit Naveed Sattar J. Wouter Jukema Heinrich V. Groesdonk Graciela Delgado Tatjana Stojaković Anna P. Pilbrow Vicky A. Cameron Mark Richards Robert N. Doughty Yan Gong Rhonda M. Cooper‐DeHoff Julie A. Johnson Markus Scholz Frank Beutner Joachim Thiery J. G. Smith Ragnar O. Vilmundarson Ruth McPherson Alexandre F.R. Stewart Sharon Cresci Petra Lenzini John A. Spertus Oliviero Olivieri Domenico Girelli Nicola Martinelli Andreas Leiherer Christoph H. Saely Heinz Drexel Axel Mündlein Peter S. Braund Christopher P. Nelson Nilesh J. Samani Daniel Kofink Imo E. Hoefer Gerard Pasterkamp Arshed A. Quyyumi Yi-An Ko Jaana Hartiala Hooman Allayee W.H. Wilson Tang Stanley L. Hazen Niclas Eriksson Claes Held Emil Hagström Lars Wallentin Axel Åkerblom Agneta Siegbahn Igor Karp Christopher Labos Louise Pilote James C. Engert James M. Brophy George Thanassoulis Peter Bogaty Wojciech Szczeklik Marcin Kaczor Marek Sanak Salim S. Virani Christie M. Ballantyne Vei-Vei Lee Eric Boerwinkle Michael V. Holmes Benjamin D. Horne Aroon D. Hingorani Folkert W. Asselbergs Riyaz Patel Bernhard K. Krämer

10.1016/s2213-8587(17)30096-7 article EN The Lancet Diabetes & Endocrinology 2017-05-29

BackgroundPrevious trials suggest lower long-term risk of mortality after invasive rather than non-invasive management patients with non-ST elevation myocardial infarction (NSTEMI), but the excluded very elderly patients. We aimed to estimate effect versus within 3 days peak troponin concentration on survival aged 80 years or older NSTEMI.MethodsRoutine clinical data for this study were obtained from five collaborating hospitals hosting NIHR Biomedical Research Centres in UK (all tertiary...

10.1016/s0140-6736(20)30930-2 article EN cc-by The Lancet 2020-08-01

Abstract Objective To determine the relation between age and troponin level its prognostic implication. Design Retrospective cohort study. Setting Five cardiovascular centres in UK National Institute for Health Research Informatics Collaborative (UK-NIHR HIC). Participants 257 948 consecutive patients undergoing testing any clinical reason 2010 2017. Main outcome measure All cause mortality. Results had measured during study period. Analyses on were performed using peak level, which was...

10.1136/bmj.l6055 article EN cc-by-nc BMJ 2019-11-20

Introduction Lung cancer screening (LCS) by low-dose computed tomography (LDCT) offers an opportunity to impact both lung and coronary heart disease mortality through detection of artery calcification (CAC). Here, we explore the value CAC cardiovascular (CVD) risk assessment in LCS participants Screen Uptake Trial (LSUT). Methods In this cross-sectional study, current ex-smokers aged 60–75 were invited a ‘lung health check’. Data collection included CVD enabling estimation 10 year using...

10.1136/thoraxjnl-2018-212812 article EN cc-by Thorax 2019-09-26
Coming Soon ...